Crona, D J
Ramirez, J
Qiao, W
de Graan, A-J
Ratain, M J
van Schaik, R H N
Mathijssen, R H J
Rosner, G L
Innocenti, F
Article History
Received: 29 July 2014
Revised: 4 December 2014
Accepted: 28 January 2015
First Online: 14 April 2015
Competing interests
: Dr Federico Innocenti and Dr Mark J Ratain disclose that they receive royalties from <i>UGT1A1</i> genotyping. Dr Gary L Rosner discloses that he owns stock in Pfizer. The remaining authors state no conflict of interest.